An in-vitro study demonstrated that CSO upregulates the PTEN protein while inhibiting the expression of p-AKT and p-PI3K proteins, thereby inducing apoptosis in human pancreatic cancer cells through the PTEN/PI3K/AKT signaling pathway (Yang et al., 2022a). This evidence concerns the gene AKT1 and pancreatic neoplasm.